Advertisement

What is Rytary?

Rytary is formulated for the treatment of Parkinson's disease. It combines the drugs carbidopa and levodopa in an extended-release capsule. Levodopa is converted into dopamine in the brain, which eases symptoms of Parkinson's (and Parkinson's-like symptoms from poisoning) including tremors, slowness of movement, and stiffness. Carbidopa prevents levodopa from being broken down before it can be effective. Rytary is not recommended for use with the antidepressant drugs called nonselective MAO inhibitors, such as phenelzine. Side effects include falling asleep without warning; drowsiness; increased risk for melanoma, glaucoma, and peptic ulcers; insomnia and/or abnormal dreams; impairment of voluntary movement; nausea, dizziness, and headache; anxiety; low blood pressure on awakening; and hallucinations or compulsive or impulsive behavior. Withdrawal symptoms may occur if patients stop taking the drug or lower the dose suddenly. 

Continue Learning about Parkinson's Disease Treatment

How effective is deep brain stimulation for treating Parkinson's disease?
UCLA HealthUCLA Health
Deep brain stimulation for Parkinson’s disease uses a surgically implanted medical device similar to...
More Answers
How long do the effects of deep brain stimulation last?
Nader Pouratian, MDNader Pouratian, MD
We don’t know how long the effects of deep brain stimulation last, because the surgery has only been...
More Answers
Where Are We in Understanding Parkinson's Disease?
Where Are We in Understanding Parkinson's Disease?
What Are the Latest Developments In Treating Alzheimer's and Parkinson's?
What Are the Latest Developments In Treating Alzheimer's and Parkinson's?

Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.